P107 HLA expression in flow crossmatch: Cell source and pronase matter
Sign Up to like & getrecommendations! Published in 2017 at "Human Immunology"
DOI: 10.1016/j.humimm.2017.06.167
Abstract: Aim Flow cytometry crossmatch (FCXM) is an important tool in pre-transplant assessment of immunologic risk. Variation in HLA antigen density (AgD) may affect FCXM interpretation. The objectives of this study are to measure HLA AgD… read more here.
Keywords: class; hla; pronase; cell ... See more keywords
Pronase independent flow cytometry crossmatching of rituximab treated patients.
Sign Up to like & getrecommendations! Published in 2018 at "Human immunology"
DOI: 10.1016/j.humimm.2017.11.006
Abstract: ABO-incompatible (ABOi) kidney transplantation has become an established strategy to increase the number of available living donors. At our center, the conditioning protocol for ABOi patients is based on anti-A/B antibody removal and depletion of… read more here.
Keywords: rituximab; rit; pronase; anti rit ... See more keywords
P137 Go pro(nase)! the importance of donor lymphocyte treatment with pronase in flow cytometric crossmatch testing
Sign Up to like & getrecommendations! Published in 2018 at "Human Immunology"
DOI: 10.1016/j.humimm.2018.07.194
Abstract: Aim Flow cytometric crossmatch (FCXM) is performed to confirm donor/recipient histocompatibility. Previous multicenter study (Liwski et al. ASHI 2012) suggested that protocol differences contribute to FCXM result variability and that pronase treatment improves B cell… read more here.
Keywords: treatment; cytometric crossmatch; flow cytometric; donor ... See more keywords